PD-1Ab21-BCMA CAR-T Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1Ab21-BCMA CAR-T Therapy, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction [Phase 2]